Literature DB >> 1996553

Issues in cerebrospinal fluid management. Acid-fast bacillus smear and culture.

R E Albright1, C B Graham, R H Christenson, W A Schell, M C Bledsoe, J L Emlet, T P Mears, L B Reller, K A Schneider.   

Abstract

Meningeal tuberculosis is an uncommon disease in the United States with an annual incidence of fewer than 200 cases. This study evaluates three approaches to improving the use of the cerebrospinal (CSF) acid-fast bacillus (AFB) smear and culture procedure: (1) education alone; (2) optional screening by which physicians can select to have the AFB analysis stopped if the initial CSF findings are unremarkable; and (3) mandatory screening before the performance of all CSF AFB analyses. With education alone, the CSF AFB culture rate decreased from 20.6% of all CSF acquisitions to 15.7% (P less than 0.001); however, the effect may have been related to a decrease in all types of AFB testing. Optional screening had no impact on the AFB testing rate. Mandatory screening significantly decreased the CSF AFB rate to 6.7% (P less than 0.001), unrelated to changes in other types of AFB testing. Laboratories that employ mandatory screening should report the screening results immediately and have a mechanism whereby physicians can bypass the screen, providing CSF AFB analysis on unremarkable fluid from high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996553     DOI: 10.1093/ajcp/95.3.418

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases.

Authors:  John A Crump; Jennifer R Corder; Nancy G Henshaw; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 3.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

4.  DNA AMPLIFICATION OF A REPETITIVE SEQUENCE - IS 6110 IN THE EARLY DIAGNOSIS OF EXTRA PULMONARY TUBERCULOSIS.

Authors:  K K Lahiri; Y K Goorha
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 6.  Evolving approaches to management of quality in clinical microbiology.

Authors:  R C Bartlett; M Mazens-Sullivan; J Z Tetreault; S Lobel; J Nivard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  Clinical evaluation of the Gen-Probe Amplified Direct Test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid.

Authors:  A M Lang; J Feris-Iglesias; C Pena; J F Sanchez; L Stockman; P Rys; G D Roberts; N K Henry; D H Persing; F R Cockerill
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.